Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies
Am J Hematol
.
2024 Mar;99(3):473-476.
doi: 10.1002/ajh.27181.
Epub 2023 Dec 21.
Authors
Rena Buckstein
1
,
Jeannie Callum
2
,
Anca Prica
3
,
David Bowen
4
,
Richard A Wells
1
,
Brian Leber
5
,
Nancy Heddle
6
,
Lisa Chodirker
1
,
Matthew Cheung
1
,
Lee Mozessohn
1
,
Karen Yee
3
,
Jennifer Gallagher
1
,
Anne Parmentier
1
,
Erin Jamula
5
,
Zoe McQuilten
7
,
Erica M Wood
7
,
Robert Weinkov
8
,
Liying Zhang
9
,
Alex Mamedov
1
,
Simon J Stanworth
10
11
12
,
Yulia Lin
13
Affiliations
1
Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
2
Department of Pathology and Molecular Medicine, Kingston Health Sciences Center, Kingston, Ontario, Canada.
3
Department of Medicine, Princess Margaret Hospital, United Health Network, Toronto, Ontario, Canada.
4
Department of Medicine, University of York, York, UK.
5
Department of Medicine, Mcmaster University, Hamilton, Ontario, Canada.
6
Mcmaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
7
Transfusion Research Unit, Division of Acute and Critical Care, Monash University, Melbourne, Victoria, Australia.
8
Malaghan Institute of Medical Research Newton, Wellington, New Zealand.
9
MacroSTAT Inc., Toronto, Ontario, Canada.
10
NHS Blood and Transplant, Oxford, UK.
11
Oxford University NHS Trust, The John Radcliffe Hospital, Oxford, UK.
12
Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
13
Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
PMID:
38126081
DOI:
10.1002/ajh.27181
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Erythrocyte Transfusion / methods
Feasibility Studies
Humans
Myelodysplastic Syndromes* / therapy
Outpatients*
Randomized Controlled Trials as Topic
Grants and funding
QOLL-14/Canadian Cancer Society Research Institute
NHSBT R&D
the Australian and New Zealand Society of Blood Transfusions (ANZSBT)
the Wellington Division of New Zealand Cancer Society
MOSPI Fund